US-based medical technology company GE Healthcare has entered into a five-year partnership with Vanderbilt University Medical Center to develop cancer immunotherapies using artificial intelligence.
The US Food and Drug Administration has announced new policies to advance the development of safe and effective cell and gene therapies.
Boston Scientific and US-based Edwards Lifesciences have agreed to settle all outstanding patent litigation between the two companies.
US law firm McGuire Woods is expanding its life sciences patent litigation team with the addition of three partners in its New York office.
Multinational pharmaceutical company Sanofi has entered into a licensing agreement with Paris-based biopharmaceutical company Biomunex.
US-based Amerigen Pharmaceuticals has lost in its bid to prove that claims in a patent owned by biopharmaceutical company UCB were covered by a prior invention.
A New York-based plastic surgery clinic has taken legal action against two former employees and a rival clinic for copyright infringement, trademark counterfeiting and dilution, and cybersquatting.
The number of international investors in life sciences start-ups in the Catalonia region in Spain has multiplied by ten in the last five years, according to a new report.
The US Supreme Court has refused to hear an appeal against a ruling that American pharmaceutical firm Merck & Co cannot collect $200 million in damages due to its misconduct during a trial.
Gilead Sciences, a biopharmaceutical company based in the US, has entered into a licensing and collaboration agreement with South Korean healthcare company Yuhan.